| |
| |
|
| Insider
Information: |
Rodman David Malcom |
| Relationship: |
Chief Medical Officer |
| City: |
Boulder |
| State: |
CO |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
78,365 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$734,828 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
78,365 |
|
|
| Total
Value |
$734,828 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alpine Immune Sciences Inc |
ALPN |
Exec Vice President an... |
2017-01-04 |
11,368 |
2016-07-01 |
0 |
Premium* |
|
|
Mineralys Therapeutics, Inc. |
MLYS |
Chief Medical Officer |
2024-04-12 |
66,997 |
2023-08-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
20 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MLYS |
Mineralys Therapeutics, I... |
Chief Medical Officer |
• – – |
2024-04-12 |
4 |
OE |
$1.08 |
$6,857 |
D/D |
6,349 |
66,997 |
0 |
- |
|
| MLYS |
Mineralys Therapeutics, I... |
Chief Medical Officer |
• – – |
2024-04-11 |
4 |
OE |
$0.54 |
$2,709 |
D/D |
5,017 |
60,648 |
0 |
- |
|
| MLYS |
Mineralys Therapeutics, I... |
Chief Medical Officer |
• – – |
2024-03-12 |
4 |
OE |
$1.08 |
$6,856 |
D/D |
6,348 |
55,631 |
0 |
- |
|
| MLYS |
Mineralys Therapeutics, I... |
Chief Medical Officer |
• – – |
2024-03-11 |
4 |
OE |
$0.54 |
$2,709 |
D/D |
5,017 |
49,283 |
0 |
- |
|
| MLYS |
Mineralys Therapeutics, I... |
Chief Medical Officer |
• – – |
2024-02-12 |
4 |
OE |
$0.54 |
$9,566 |
D/D |
11,366 |
44,266 |
0 |
- |
|
| MLYS |
Mineralys Therapeutics, I... |
Chief Medical Officer |
• – – |
2024-01-12 |
4 |
OE |
$1.08 |
$6,856 |
D/D |
6,348 |
32,900 |
0 |
- |
|
| MLYS |
Mineralys Therapeutics, I... |
Chief Medical Officer |
• – – |
2024-01-11 |
4 |
OE |
$0.54 |
$2,709 |
D/D |
5,017 |
26,552 |
0 |
- |
|
| MLYS |
Mineralys Therapeutics, I... |
Chief Medical Officer |
• – – |
2023-12-11 |
4 |
OE |
$0.54 |
$2,710 |
D/D |
5,018 |
20,069 |
0 |
- |
|
| MLYS |
Mineralys Therapeutics, I... |
Chief Medical Officer |
• – – |
2023-11-13 |
4 |
OE |
$0.54 |
$2,709 |
D/D |
5,017 |
15,051 |
0 |
- |
|
| MLYS |
Mineralys Therapeutics, I... |
Chief Medical Officer |
• – – |
2023-11-03 |
4 |
OE |
$0.54 |
$5,418 |
D/D |
10,034 |
10,034 |
0 |
- |
|
| MLYS |
Mineralys Therapeutics, I... |
Chief Medical Officer |
• – – |
2023-08-11 |
4 |
S |
$12.81 |
$2,012,336 |
D/D |
(157,091) |
0 |
0 |
- |
|
| MLYS |
Mineralys Therapeutics, I... |
Chief Medical Officer |
• – – |
2023-08-11 |
4 |
OE |
$0.54 |
$125,967 |
D/D |
157,091 |
76,182 |
0 |
- |
|
| MLYS |
Mineralys Therapeutics, I... |
Chief Medical Officer |
• – – |
2023-08-10 |
4 |
S |
$13.16 |
$982,065 |
D/D |
(74,625) |
0 |
0 |
- |
|
| MLYS |
Mineralys Therapeutics, I... |
Chief Medical Officer |
• – – |
2023-08-10 |
4 |
OE |
$0.54 |
$40,298 |
D/D |
74,625 |
74,625 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Exec Vice President and CMO |
• – – |
2017-01-04 |
4 |
AS |
$2.27 |
$15,179 |
D/D |
(6,687) |
11,368 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Exec Vice President and CMO |
• – – |
2017-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,055 |
18,055 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Exec Vice President and CMO |
• – – |
2016-10-04 |
4 |
AS |
$7.96 |
$46,327 |
D/D |
(5,820) |
12,236 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Exec Vice President and CMO |
• – – |
2016-10-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,056 |
18,056 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Exec Vice President and CMO |
• – – |
2016-07-05 |
4 |
AS |
$4.66 |
$27,727 |
D/D |
(5,950) |
12,105 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Exec Vice President and CMO |
• – – |
2016-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,055 |
18,055 |
0 |
- |
|
20 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
